abstract |
The present invention provides a method for screening a preventive or therapeutic agent for diseases caused by interleukin-6, interleukin-13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5, and a method for screening for a disease caused by interleukin-6, interleukin-13 A prophylactic or therapeutic agent for diseases caused by , TNF, G-CSF, CXCL1, CXCL2, or CXCL5. A method of screening a preventive or therapeutic agent for diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5, the method being selected from the expression change of MEX3B gene or MEX3B protein , and at least one of the group consisting of functional changes of the MEX3B protein as an index. |